
Pensions
Sanofi, Legal & General Complete $1.74B Annuity Buy-In
The plan’s second transaction with L&G kicks off 2025, which could be another record year for pension risk transfer volume.
Biomedical researchers are discovering drugs that improve patient care and although many needs remain unmet, investment opportunities emerge.
TPR pressures French biopharmaceutical company to boost UK defined benefit plan funding.